We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 28

Draft patent (amendment) rules, 2018 published for objections and suggestions
  • Khaitan & Co
  • India
  • December 12 2018

The Ministry of Commerce and Industry has published Draft Patent (Amendment) Rules, 2018 (Draft Rules) for objections and suggestions. The key


Delhi High Court awards damages and costs in addition to royalty fees in a standard essential patent infringement suit
  • Khaitan & Co
  • USA, India
  • July 19 2018

Recently, the Delhi High Court, in the matter of Koninklijke Philips Electronics N.V. (Plaintiff) v Rajesh Bansal and Ors (Defendants), after


Revised guidelines for examining computer related inventions by the Patent Office issued
  • Khaitan & Co
  • India
  • July 4 2017

The Indian Patent Office (IPO) has once again revisited the guidelines for examination of Computer Related Inventions (CRIs) and issued revised


The Patent (Amendment) Rules, 2016 come into force
  • Khaitan & Co
  • India
  • May 19 2016

The Patent (Amendment) Rules, 2016 (Revised Rules) have come into force from 16 May 2016. The key highlights of the Revised Rules are broadly set out


Delhi High Court dismisses Ericsson’s plea challenging CCI orders
  • Khaitan & Co
  • India
  • April 4 2016

In a petition filed by Telefonaktiebolaget LM Ericsson (Ericsson) challenging two orders of the Competition Commission of India (CCI), the Delhi High


Issuance of Revised Guidelines for Examining Computer Related Inventions by the Patent Office
  • Khaitan & Co
  • India
  • February 23 2016

The Indian Patent office (IPO) had earlier issued guidelines on 21 August 2015 to Patent Examiners relating to the examination of computer related


Lee pharma’s compulsory license application for saxagliptin rejected by Indian Patent Office
  • Khaitan & Co
  • India
  • January 22 2016

In an order dated 19 January 2016 (Order), the Controller General of Patents and Trademarks (CGPTM) rejected the application for Compulsory License


Pfizer’s Patent Application relating to rheumatoid arthritis drug (Tofacitinib) rejected by Indian patent
  • Khaitan & Co
  • India
  • September 9 2015

The Indian Patent Office (IPO) has passed an order on 3 September 2015 (Order) rejecting patent application no. 991MUMNP2003 (Patent Application)


Compulsory license for AstraZeneca’s diabetes management drug Saxagliptin?
  • Khaitan & Co
  • India
  • July 7 2015

In a recent development, a compulsory license (CL) application has been filed for the patent covering AstraZeneca's diabetes management drug


Delhi High Court sets aside Patent Office order rejecting Gilead’s patent application for Hepatitis C drug Solvadi on procedural grounds
  • Khaitan & Co
  • India
  • February 4 2015

On 30 January 2015, the Delhi High Court set aside an order dated 13 January 2015 (Order) of the Indian Patent Office (IPO) rejecting a patent to